Comparing two oxytocin doses for bleeding control in high-risk cesarean births
Treatments studied
Part of Women’s health & pregnancy clinical trials.
This study compares two doses of oxytocin (a medicine given during cesarean section to prevent heavy bleeding) to see which works better for women with high-risk pregnancies. If you are having a planned cesarean and have certain risk factors, this trial may help find the best dose for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled for a planned (not emergency) cesarean section.
- You have a condition that makes this a high-risk pregnancy – like high blood pressure, diabetes, a blood disorder, placenta problem, or carrying twins.
- You may have had heavy bleeding after a past birth, or have a history of infertility treatment or endometriosis.
- You are not allergic to oxytocin (a medicine that helps the womb contract).
- You did not already have labor contractions before the cesarean (exhausted uterus) or a condition called Couvelaire uterus.
- You are not on medicines that prevent blood clots (like blood thinners) unless your doctor approves.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two medicines—carbetocin and oxytocin—given during a planned cesarean to help prevent heavy bleeding after delivery. It is for women who have certain risk factors for uterine atony (when the uterus does not tighten up after birth).
This study compares two medications (tranexamic acid and oxytocin) given directly into the uterus during a planned cesarean section to see which works better at reducing blood loss. It is for women with a single, full-term pregnancy and no major health complications.
This trial tests whether giving a specific combination of three medicines during a planned c-section is better than one medicine alone for preventing postpartum hemorrhage (heavy bleeding after birth).
This trial tests a new way to give oxytocin—a tablet placed under the tongue—right after the baby is born, to prevent dangerous heavy bleeding. If it works, it could be a simple, needle-free option for mothers everywhere.
This study looks at how oxytocin (a medicine often used to help with labor and uterine contractions) moves through the body and what it does during a non-emergency C-section. It may help improve how oxytocin is used in the future for safer, more predictable delivery care.
This trial compares giving oxytocin as a single injection versus a slow drip during C-sections in people at high risk for heavy bleeding after delivery. The goal is to find which method works better to prevent postpartum hemorrhage.
Hear when a new Post Partum Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.